SCHEMBL18952525

SCHEMBL18952525

NC1C2CCCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12127986 0.89
SCHEMBL12128019 0.79
SCHEMBL16518854 0.72
SCHEMBL1404038 0.70 SLC18A3 (0.44)
Hydrochloric Acid SCHEMBL29131458 0.70 CHRNA7 (0.35)
SCHEMBL30667167 0.70 OPRM1 (0.38)
SCHEMBL3076098 0.68
SCHEMBL19468663 0.68
SCHEMBL18821982 0.68
Hydrochloric Acid SCHEMBL31329690 0.67 TDP1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519418-A1 BRIDGED PIPERIDINE DERIVATIVES H. Hoffnabb-La Roche Ag (CH) 2019-08-07 EP disclosed
EP-3475279-A1 TRIAZOLOPYRIDINES AS GAMMA-SECRETASE MODULATORS H. Hoffnabb-La Roche Ag (CH) 2019-05-01 EP disclosed
EP-3386978-A1 BRIDGED PIPERIDINE DERIVATIVES H. Hoffnabb-La Roche Ag (CH) 2018-10-17 EP disclosed
WO-2018060300-A1 BRIDGED PIPERIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2018-04-05 WO disclosed
WO-2018001918-A1 TRIAZOLOPYRIDINES AS GAMMA-SECRETASE MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2018-01-04 WO disclosed
WO-2017097728-A1 BRIDGED PIPERIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2017-06-15 WO disclosed